Skip to main content

Table 1 Clinical pathological parameters of the UCEC patients included in this study

From: Elevated expression of LPCAT1 predicts a poor prognosis and is correlated with the tumour microenvironment in endometrial cancer

Characteristic Level Overall
n   552
Clinical stage, n (%) Stage I 342 (62%)
Stage II 51 (9.2%)
Stage III 130 (23.6%)
Stage IV 29 (5.3%)
Primary therapy outcome, n (%) PD 20 (4.2%)
SD 6 (1.2%)
PR 12 (2.5%)
CR 442 (92.1%)
Age, n (%) ≤ 60 206 (37.5%)
> 60 343 (62.5%)
BMI, n (%) ≤ 30 212 (40.8%)
> 30 307 (59.2%)
Histological type, n (%) Endometrioid 410 (74.3%)
Mixed 24 (4.3%)
Serous 118 (21.4%)
Histologic grade, n (%) G1 98 (18.1%)
G2 120 (22.2%)
G3 323 (59.7%)
OS event, n (%) Alive 458 (83%)
Dead 94 (17%)
PFI event, n (%) Alive 423 (76.6%)
Dead 129 (23.4%)
Diabetes, n (%) No 328 (72.7%)
Yes 123 (27.3%)
Tumour invasion (%), n (%)  < 50 259 (54.6%)
≥ 50 215 (45.4%)